Study confirms benefit of combination therapy for Alzheimer's disease

EureikAlert
Sue McGreevey
Massachusetts General Hospital
First long-term study finds that treatment slows symptom progression, benefits last for years
Extended treatment with Alzheimer's disease drugs can significantly slow the rate at which the disorder advances, and combination therapy with two different classes of drugs is even better at helping patients maintain their ability to perform daily activities. Results from the first long-term study of the real-world use of Alzheimer's drugs, published by researchers from Massachusetts General Hospital in the July/September issue of Alzheimer Disease and Associated Disorders, support a level of effectiveness that may not be immediately apparent to patients or their family members.
"There has been the impression that these drugs only work for... read the whole article